| Application no. and date | 21178526.6 (espacenet) (Federated) (European Patent Register), 20180713 | | Patent/reg. no. and date | DK/EP 3943070, 20231122 | | Publication date | 20220126 | | Priority no. and date | EP 17181354, 20170714, EP 18167463, 20180416 | | EP pub. no. and date |
EP 3943070 20220126 | | Effective date | | | Applicant/owner | Janssen Pharmaceutica NV, Turnhoutseweg 30
2340 Beerse, BE | | Applicant ref. no. | BB238387EPDK | | Inventor | Andries, Koenraad, Jozef, Lodewijk, Marcel,
2340 Beerse, BE,
BASSTANIE, Esther, Dina, Guido,
2340 Beerse, BE,
BERNINI, Maristella,
2340 Beerse, BE | | Representative | Novagraaf Brevets, Bâtiment O2, 2 rue Sarah Bernhardt CS90017
F-92665 Asnières-sur-Seine cedex, FR | | Opponent | | | IPC Class | A61K 31/47 (2006.01) , A61K 47/26 (2006.01) , A61K 9/10 (2006.01) , A61P 31/06 (2006.01) , A61P 31/08 (2006.01) | | Title | LANGTIDSVIRKENDE FORMULERINGER AF BEDAQUILIN | | Int. application no. | | | Int. publication no. | | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
